Related Experiment Videos
[Demonstration of a fifth locus implicated in familial hypertrophic cardiomyopathies]
C Hengstenberg1, P Charron, R Isnard
1INSERM U153, hôpital Pitié-Salpêtrière, Paris.
Insights
Familial hypertrophic cardiomyopathy (HCM) is often inherited. A study in a West Indian family identified a fifth gene linked to HCM, suggesting greater genetic heterogeneity than previously understood.
Area of Science:
- Genetics
- Cardiology
- Molecular Biology
Background:
- Hypertrophic cardiomyopathy (HCM) is a genetic heart condition, with approximately 50% of cases being familial and inherited in an autosomal dominant pattern.
- The beta myosin heavy chain (beta MHC) gene on chromosome 14 was the first identified genetic cause, but it explains only about 30% of familial HCM cases.
- Recent discoveries have identified additional loci on chromosomes 1q3, 11p13-q13, and 15q2, indicating the genetic complexity of HCM.
Purpose of the Study:
- To investigate potential novel genetic factors contributing to familial hypertrophic cardiomyopathy (HCM).
- To perform linkage analysis in a West Indian family to identify genes responsible for HCM.
- To assess the genetic heterogeneity of familial HCM beyond known loci.
Main Methods:
- Linkage analysis was conducted on a West Indian family with a history of hypertrophic cardiomyopathy (HCM).
- Microsatellite markers were used to analyze the distribution of the disease within the family.
- Markers targeting previously identified loci (beta MHC, 1q3, 11p13-q13, 15q2) and four new markers were employed.
Main Results:
- The study found no genetic linkage between hypertrophic cardiomyopathy (HCM) in the studied family and the beta MHC gene.
- No significant correlation was observed between the disease and the genetic markers for loci on chromosomes 1q3, 11p13-q13, and 15q2.
- These findings indicate the presence of at least a fifth gene implicated in familial HCM within this cohort.
Conclusions:
- The genetic basis of familial hypertrophic cardiomyopathy (HCM) is more complex and heterogeneous than previously recognized.
- A novel gene, distinct from those on chromosomes 14, 1q3, 11p13-q13, and 15q2, is implicated in HCM in the studied West Indian family.
- Further research is warranted to identify this fifth gene and elucidate its role in hypertrophic cardiomyopathy pathogenesis.
Abstract:
Hypertrophic cardiomyopathy is familial in about 50% of cases and is transmitted in the autosomal dominant mode. The first morbid gene implicated in the disease was the gene coding the beta myosin heavy chain (beta MHC) on chromosome 14. However, only 30% of families have this genetic abnormality. Recently, three new loci have been identified on chromosomes 1q3, 11p13-q13 and 15q2. In order to determine whether other genes could be implicated in the disease a linkage analysis study was performed in a West Indian family. The method is based on the analysis of the distribution of the disease in the family and the microsatellite markers. The microsatellites used were those which recognised the 4 loci previously mentioned and 4 new markers situated and arranged with respect to known microsatellites. The results show that in the family studied, the disease did not concord with the markers of the beta MHC gene or with those recognising the loci on chromosomes 1q3, 11p13-q13 and 15q2. There is, therefore, a fifth gene implicated in familial HCM. The heterogeneity of the disease seems even greater than originally thought.